Novozymes
Search results
We offer 1064 job opportunities. Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
In Malaysia, Novo Nordisk works in partnership with key stakeholders within the community to improve the lives of people with chronic conditions like diabetes and obesity, towards limiting the social and economic impact of the disease.
At Novo Nordisk, you will have the opportunity to build a life-changing career in a global business environment. Join us and make a difference.
47301 Petaling Jaya Selangor. +60 3 7882 8888. https://www.dksh.com/global-en/novonordiskpharmatech. Malaysia. Explore more. The right solution makes a world of difference for you and your patients. Dive deeper into the insights and science behind our exceptional solutions.
6 days ago · Novo Nordisk is a leading global healthcare company, founded in 1923 and headquartered in Denmark. Our purpose is to drive change to defeat diabetes and other serious chronic diseases.
Dec 15, 2023 · For Novo Nordisk – Malaysia presents a new set of challenges. Based on the National Health and Morbidity Survey 2019, there are approximately 3.9 million Malaysians living with diabetes.
A-9-2 Level 9, Tower A Menara UOA Bangsar, No.5 Jalan Bangsar Utama 1, 59000 Kuala Lumpur Malaysia. life changing career... where your talents benefits you and millions of others. Headquartered in Denmark, Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care.
Sep 15, 2014 · Novo Nordisk is a global healthcare company with 90 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy.
Nov 11, 2021 · Novo Nordisk, a leading global healthcare company, together with the Non-Communicable Disease Section of the Disease Control Division, Ministry of Health Malaysia (MOH), organised a media forum in conjunction with World Diabetes Day 2021.
Jun 18, 2019 · Saxenda (liraglutide 3 mg) is a once-daily glucagon-like peptide-1 (GLP-1) analogue with 97% similarity to naturally occurring human GLP-1, a hormone that is released in response to food intake.
